Disc Medicine, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-64.2M | $88.0M |
| FY2022 | — | $176.6M | $194.6M |
| FY2023 | $0 | $345.1M | $360.4M |
| FY2024 | $28.3M | $443.6M | $192.4M |
| FY2025 | $29.2M | $739.8M | $91.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $-64.2M | $88.0M |
| FY2022 | — | $176.6M | $194.6M |
| FY2023 | $0 | $345.1M | $360.4M |
| FY2024 | $28.3M | $443.6M | $192.4M |
| FY2025 | $29.2M | $739.8M | $91.1M |